Калдыгуль Кабаковна Смагулова

Калдыгуль Кабаковна Смагулова

Auto-generated profile, based on publicly available information

Калдыгуль Кабаковна Смагулова

Kazakh Institute of Oncology and Radiology

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2025 in Voprosy onkologii
Verified
Journal Article
Open access
ВСВладимир Федорович Семиглазов
Владимир Федорович Семиглазов
ПКПетр Владимирович Криворотько
Петр Владимирович Криворотько
ТСТатьяна Юрьевна Семиглазова
Татьяна Юрьевна Семиглазова
ЕАЕлена Владимировна Артамонова
Елена Владимировна Артамонова
АААнна Сергеевна Артемьева
Анна Сергеевна Артемьева
ЮШЮлиана Сергеевна Шатова
Юлиана Сергеевна Шатова
В статье представлены результаты голосования I Cанкт-Петербургского международного консенсуса по диагностике и лечению рака молочной железы «Белые ночи 2024», посвященного наиболее актуальным и спорным вопросам диагностики, хирургической тактики, лучевой терапии и системного лечения данной категории пациентов. Под председательством член-корреспондента РАН, профессора Владимира Федоровича Семиглазова в международном консенсусе приняли участие 38 экспертов в области диагностики и лечения рака молочной железы (РМЖ), проголосовавших в ходе прямого эфира по 32 вопросам, разделенным на блоки раннего и метастатического РМЖ. Проведение II Cанкт-Петербургского международного консенсуса по диагностике и лечению РМЖ «Белые ночи 2025» запланировано со 2 по 5 июля 2025 года.

30 September 2023 in Oncologia i Radiologia Kazakhstana
Verified
Journal Article
Closed access
Dilyara KaidarovaDilyara Kaidarova
Dilyara Kaidarova
NON. Omarbayeva
N. Omarbayeva
DOD. Omarov
D. Omarov
AAA. Abdrakhmanova
A. Abdrakhmanova
KSK. Smagulova
K. Smagulova
TGTatyana Goncharova
Tatyana Goncharova
Relevance: Breast cancer (BC) is one of the major health problems in the Republic of Kazakhstan. Genome-wide association studies (GWAS) are used to identify genetic factors contributing to breast cancer development in Kazakhstan and worldwide. The GWAS method consistently helps to find associations between certain single nucleotide polymorphisms (SNPs) in the genome and the development of pathological conditions, including breast cancer, by identifying more than 170 genomic sites. In addition to searching for loci associated with BC, these studies have expanded our understanding of BC heritability using SNPs located in regulatory areas and identifying DNA variants associated with drug metabolism for treatment personalization purposes. The study aimed to highlight the key concepts of modern methods in genetics based on GWAS. Methods: A literature search in PubMed, Scopus, GWAS Catalog, Cochrane Database of Systematic Reviews, etc., was performed to select and analyze relevant information Results: The article describes significant GWAS studies in the field of breast cancer, describes certain genes associated with the development of the disease, identifies shortcomings, and identifies further strategies for the development of GWAS in the Republic of Kazakhstan Conclusion: The results of this study have improved our understanding of the biological mechanisms that contribute to breast cancer risk and may ultimately lead to the development of new targeted therapies for the disease

1 January 2019 in Современные проблемы науки и образования (Modern Problems of Science and Education)
Verified
Journal Article
Open access
KSK.K. Smagulova
K.K. Smagulova
DKD.R. Kaydarova
D.R. Kaydarova
NCN.A. Chichua
N.A. Chichua
EIE.I. Ishkinin
E.I. Ishkinin

10 October 2023 in Oncologia i Radiologia Kazakhstana
Verified
Journal Article
Closed access
Dilyara KaidarovaDilyara Kaidarova
Dilyara Kaidarova
NON. Omarbayeva
N. Omarbayeva
DOD. Omarov
D. Omarov
AAA. Abdrakhmanova
A. Abdrakhmanova
KSK. Smagulova
K. Smagulova
TGTatyana Goncharova
Tatyana Goncharova
Relevance: Breast cancer (BC) is one of the major health problems in the Republic of Kazakhstan. Genome-wide association studies (GWAS) are used to identify genetic factors contributing to breast cancer development in Kazakhstan and worldwide. The GWAS method consistently helps to find associations between certain single nucleotide polymorphisms (SNPs) in the genome and the development of pathological conditions, including breast cancer, by identifying more than 170 genomic sites. In addition to searching for loci associated with BC, these studies have expanded our understanding of BC heritability using SNPs located in regulatory areas and identifying DNA variants associated with drug metabolism for treatment personalization purposes. The study aimed to highlight the key concepts of modern methods in genetics based on GWAS. Methods: A literature search in PubMed, Scopus, GWAS Catalog, Cochrane Database of Systematic Reviews, etc., was performed to select and analyze relevant information. Results: The article describes significant GWAS studies in the field of breast cancer, describes certain genes associated with the development of the disease, identifies shortcomings, and identifies further strategies for the development of GWAS in the Republic of Kazakhstan. Conclusion: The results of this study have improved our understanding of the biological mechanisms that contribute to breast cancer risk and may ultimately lead to the development of new targeted therapies for the disease.

3 March 2020 in Siberian journal of oncology
Verified
Journal Article
Open access
PDF file
DKD. R. Kaydarova
D. R. Kaydarova
KSK. K. Smagulova
K. K. Smagulova
NCN. A. Chichua
N. A. Chichua
EUE. A. Ukolova
E. A. Ukolova
AKA. Z. Kurmankulova
A. Z. Kurmankulova
EIE. I. Ishkinin
E. I. Ishkinin
ИЗУЧЕНИЕ ВЗАИМОСВЯЗИ МУТАЦИЙ ГЕНА KRAS У БОЛЬНЫХ КОЛОРЕКТАЛЬНЫМ РАКОМ В ЗАВИСИМОСТИ ОТ ПОЛА, ВОЗРАСТА И РАСЫ В ПОПУЛЯЦИИ РЕСПУБЛИКИ КАЗАХСТАН

30 December 2022 in Oncologia i Radiologia Kazakhstana
Verified
Journal Article
Closed access
Dilyara KaidarovaDilyara Kaidarova
Dilyara Kaidarova
AAA. Abdrakhmanova
A. Abdrakhmanova
MDM. Dmitrenko
M. Dmitrenko
ABA. Baizhigitov
A. Baizhigitov
NCN. Chichua
N. Chichua
SKS. Kaldarbekov
S. Kaldarbekov
Relevance: Male breast cancer (BC) has always been behind female BC in detection, treatment, and surveillance. Lower BC frequency in men limits the usefulness of screening. However, BC incidence in men is growing. This paper demonstrate the results of surgical treatment and typical changes in clinical and morphological manifestations of male breast cancer under chemotherapy and surgery. Methods: The article describes a clinical case of a male patient diagnosed with “Cancer of the right breast St III (T4NxM0), edematous-infiltrative form with an intraductal component, upper outer localization. Immunohistochemically luminal subtype B without Her2neu expression”; the condition – after six neoadjuvant chemotherapy courses. Results: Ultrasonography of the mammary glands conducted after six preoperative courses of chemotherapy showed a hypoechoic formation, centralized, with fuzzy, uneven contours, 52.5×48.2×46.1 mm in size, V=60.98 cm3. Compared to March 2022 (the presence of a formation in the right breast craniolateral quadrant, with precise uneven contours, 9.0 cm in size, with infiltrating growth), the tumor formation decreased to US BI-RADS R6, L2. The multidisciplinary council prescribed surgery to the extent of radical mastectomy by Madden on the right and simple mastectomy on the left. The surgery was performed in August 2022. According to a postoperative histological conclusion, the therapeutic pathomorphism was index RCB-2.233, class RCB-II. Conclusion: This article shares the results of systemic and surgical treatment of a man with breast cancer. Considering the clinical picture and anamnesis, literature data, and the clinical protocol, the multidisciplinary group recommended radiation therapy with adjuvant endocrine therapy with tamoxifen for an initial period of five years. * clinical case, male breast cancer (BC), luminal subtype B without Her2neu expression, mastectomy, therapeutic pathomorphism, radiation therapy, endocrine therapy.